Format

Send to

Choose Destination
Biomed Opt Express. 2016 Mar 14;7(4):1240-50. doi: 10.1364/BOE.7.001240. eCollection 2016 Apr 1.

Synergistic chemotherapy by combined moderate hyperthermia and photochemical internalization.

Author information

1
Beckman Laser Institute, University of California, Irvine,, Irvine, CA 92612 USA.
2
Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, NV 89154, USA.
3
Dept. of Radiation Biology The Norwegian Radium Hospital, Oslo University Hospital, Oslo Norway.
4
Beckman Laser Institute, University of California, Irvine,, Irvine, CA 92612 USA; Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, NV 89154, USA.

Abstract

Combination therapies of photochemical internalization (PCI) and moderate hyperthermia (MHT) were investigated in an in vitro system consisting of human and rat glioma spheroids. PCI using the amphiphilic photosensitizer, AlPcS2a and two anti cancer agents BLM or 5-FU were used. Spheroids were irradiated with λ = 670 nm laser light in an incubator at temperatures ranging from 37 to 44°C. For each temperature investigated, spheroids were divided into 4 groups: control, drug-only, photodynamic therapy (PDT), and PCI. PDT and PCI spheroids were exposed to radiant exposures ranging from 0.3 to 2.5 J cm(-2) using an irradiance of 5 mW cm(-2). Toxicity was evaluated from spheroid growth kinetics. The combination of PCI and MHT resulted in significant increases in BLM efficacy at 44°C for both cell line derived spheroids compared to controls at 37°C over the range of radiant exposures examined. 5-FU PCI was ineffective for the human cell line at both 37 and 44°C.

KEYWORDS:

(140.0140) Lasers and laser optics; (140.3070) Infrared and far-infrared lasers

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center